drugset / Trial / NCT01758523
Dutasteride Treatment for the Reduction of Heavy Drinking in Men
Phase 4
Completed
189 enrolled
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will examine the safety and potential benefit of the medication dutasteride to help men reduce or stop drinking alcohol.
Timeline
- Start
- 2013-01
- Primary completion
- 2018-02-28
- Completion
- 2018-02-28
Outcome
Mixed primary results
registry analysis (other test); Dutasteride vs Sugar Pill; p = 0.002; Mixed Models Analysis NCT01758523 ↗
paper CONCLUSION: Dutasteride 1 mg daily was efficacious in reducing the number of heavy drinking days and drinks per week in treatment-seeking men. PMID 38684046 ↗
registry analysis (other test); Dutasteride vs Sugar Pill; p = 0.057; Odds Ratio (OR) 2.49 (95% CI 0.96 to 6.45); Chi-squared NCT01758523 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | 1 mg | Oral |